Drreddys Laboratories reported 19.25 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
ANI Pharmaceuticals 27.31 10.68 Mar/2026
Aurora Cannabis 23.27 0 Mar/2026
Bayer 3.4 8.75 Mar/2026
Cipla 23.56 4.18 Mar/2026
Corcept Therapeutics 113.58 71.67 Mar/2026
Drreddys Laboratories 19.25 0.98 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lonza 34.34 2.58 Dec/2025
Novartis 20.17 2.32 Mar/2026
Pacira 38.58 14.1 Mar/2026
Phibro Animal Health 13.82 4.04 Dec/2025
Prestige Brands 15.31 3.1 Dec/2025
Richter Gedeon 10.77 2.94 Mar/2026
Sun Pharmaceuticals 39.44 5.7 Dec/2025
Supernus Pharmaceuticals 44.21 66.17 Mar/2026
Teva Pharmaceutical Industries 10.07 0.04 Mar/2026